Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$0.63 - $1.14 $34,209 - $61,901
-54,300 Reduced 7.87%
635,800 $527,000
Q3 2023

Nov 08, 2023

BUY
$1.12 - $1.88 $43,232 - $72,568
38,600 Added 5.92%
690,100 $779,000
Q2 2023

Aug 09, 2023

BUY
$1.31 - $2.04 $77,814 - $121,176
59,400 Added 10.03%
651,500 $1.04 Million
Q1 2023

May 10, 2023

SELL
$1.45 - $2.95 $33,785 - $68,735
-23,300 Reduced 3.79%
592,100 $899,000
Q4 2022

Feb 08, 2023

BUY
$2.02 - $3.25 $74,942 - $120,575
37,100 Added 6.42%
615,400 $1.48 Million
Q3 2022

Nov 09, 2022

BUY
$1.96 - $3.14 $66,444 - $106,446
33,900 Added 6.23%
578,300 $1.19 Million
Q2 2022

Aug 09, 2022

BUY
$1.3 - $2.64 $76,180 - $154,704
58,600 Added 12.06%
544,400 $1.06 Million
Q1 2022

May 09, 2022

BUY
$2.35 - $3.47 $177,425 - $261,985
75,500 Added 18.4%
485,800 $1.2 Million
Q4 2021

Feb 08, 2022

BUY
$2.92 - $5.74 $49,932 - $98,154
17,100 Added 4.35%
410,300 $1.32 Million
Q3 2021

Nov 08, 2021

BUY
$4.98 - $6.63 $183,762 - $244,647
36,900 Added 10.36%
393,200 $2.06 Million
Q2 2021

Aug 06, 2021

BUY
$2.56 - $5.49 $77,824 - $166,896
30,400 Added 9.33%
356,300 $1.96 Million
Q1 2021

May 07, 2021

BUY
$2.69 - $5.25 $39,812 - $77,700
14,800 Added 4.76%
325,900 $886,000
Q4 2020

Feb 05, 2021

BUY
$3.17 - $4.49 $71,325 - $101,025
22,500 Added 7.8%
311,100 $989,000
Q3 2020

Nov 09, 2020

BUY
$2.98 - $5.2 $129,034 - $225,160
43,300 Added 17.65%
288,600 $1.15 Million
Q2 2020

Aug 05, 2020

BUY
$2.29 - $4.24 $49,922 - $92,432
21,800 Added 9.75%
245,300 $964,000
Q4 2019

Feb 06, 2020

BUY
$2.41 - $4.4 $22,654 - $41,360
9,400 Added 4.39%
223,500 $910,000
Q3 2019

Nov 12, 2019

BUY
$2.17 - $3.14 $14,756 - $21,352
6,800 Added 3.28%
214,100 $552,000
Q2 2019

Aug 02, 2019

BUY
$2.53 - $3.04 $81,719 - $98,192
32,300 Added 18.46%
207,300 $622,000
Q1 2019

May 10, 2019

BUY
$2.51 - $3.73 $46,434 - $69,005
18,500 Added 11.82%
175,000 $520,000
Q1 2018

May 04, 2018

BUY
$3.51 - $6.04 $25,623 - $44,092
7,300 Added 4.89%
156,500 $737,000
Q3 2017

Nov 03, 2017

BUY
$3.48 - $4.44 $519,216 - $662,448
149,200
149,200 $658,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.